|
1. Richart RM: Cervical intraepithelial neoplasia. Pathol Annu 1973, 8:301-328. 2. Mitchell MF, Tortolero-Luna G, Wright T, Sarkar A, Richards-Kortum R, Hong WK, Schottenfeld D: Cervical human papillomavirus infection and intraepithelial neoplasia: a review. J Natl Cancer Inst Monogr 1996(21):17-25. 3. Traen K, Svane D, Kryger-Baggesen N, Bertelsen K, Mogensen O: Stage Ib cervical cancer during pregnancy: planned delay in treatment--case report. Eur J Gynaecol Oncol 2006, 27(6):615-617. 4. Proietto A: Gynaecological cancer surgery. Best Pract Res Clin Obstet Gynaecol 2006, 20(1):157-172. 5. Gonzalez D, Hernandez E, Anderson L, Heller P, Atkinson BF: Clinical Significance of a cervical cytologic diagnosis of atypical squamous cells of undetermined significance. Favoring a reactive process or low grade squamous intraepithelial lesion. J Reprod Med 1996, 41(10):719-723. 6. Chambers AF, Groom AC, MacDonald IC: Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002, 2(8):563-572. 7. Overall CM, Lopez-Otin C: Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2002, 2(9):657-672. 8. Dang CV: c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 1999, 19(1):1-11. 9. Straughn JM, Jr., Richter HE, Conner MG, Meleth S, Barnes MN: Predictors of outcome in small cell carcinoma of the cervix--a case series. Gynecol Oncol 2001, 83(2):216-220. 10. Zhang J, Jung K, Lein M, Kristiansen G, Rudolph B, Hauptmann S, Schnorr D, Loening SA, Lichtinghagen R: Differential expression of matrix metalloproteinases and their tissue inhibitors in human primary cultured prostatic cells and malignant prostate cell lines. Prostate 2002, 50(1):38-45. 11. Steeg PS, Bevilacqua G, Pozzatti R, Liotta LA, Sobel ME: Altered expression of NM23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis. Cancer Res 1988, 48(22):6550-6554. 12. Florenes VA, Aamdal S, Myklebost O, Maelandsmo GM, Bruland OS, Fodstad O: Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression. Cancer Res 1992, 52(21):6088-6091. 13. Howlett AR, Petersen OW, Steeg PS, Bissell MJ: A novel function for the nm23-H1 gene: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest. J Natl Cancer Inst 1994, 86(24):1838-1844. 14. Kantor JD, McCormick B, Steeg PS, Zetter BR: Inhibition of cell motility after nm23 transfection of human and murine tumor cells. Cancer Res 1993, 53(9):1971-1973. 15. Leone A, Flatow U, VanHoutte K, Steeg PS: Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. Oncogene 1993, 8(9):2325-2333. 16. Ohba K, Miyata Y, Koga S, Kanda S, Kanetake H: Expression of nm23-H1 gene product in sarcomatous cancer cells of renal cell carcinoma: correlation with tumor stage and expression of matrix metalloproteinase-2, matrix metalloproteinase-9, sialyl Lewis X, and c-erbB-2. Urology 2005, 65(5):1029-1034. 17. Chen SY, Wang XQ, Li XM, Chen YX, Wu CQ: [Expressions of P16 and nm23-H1 in nasopharyngeal cacinoma and their clinical significance]. Di Yi Jun Yi Da Xue Xue Bao 2005, 25(3):342-344, 348. 18. Che GW, Zhou QH, Zhu W, Wang YP, Qin Y, Liu LX, Chen XH, Sun YL, Sun ZF: [Molecular mechanism of reversing metastatic phenotype in human high-metastatic large cell lung cancer cell line L9981 by nm23-H1]. Ai Zheng 2005, 24(3):278-284. 19. Chen HY, Hsu CT, Lin WC, Tsai HD, Chang WC: Prognostic value of nm23 expression in stage IB1 cervical carcinoma. Jpn J Clin Oncol 2001, 31(7):327-332. 20. Kogan EA, Shvets SI, Kovalenko VL, Soboleva Iu V: [Correlation of proliferation, apoptosis, angiogenesis and metastasizing in various histogenetic types of pulmonary cancer (an immunohistochemical investigation)]. Arkh Patol 2004, 66(6):33-38. 21. Zheng CL, Wen JF, Huang Y: [Expression and significance of PTEN and nm23 in the metastasis of gallbladder cancer]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2005, 30(1):46-48. 22. Liu WK, Chu YL, Zhang F, Chen P, Cheng F, Wang H, Jia YY, Ma TY: The relationship between HPV16 and expression of CD44v6, nm23H1 in esophageal squamous cell carcinoma. Arch Virol 2005, 150(5):991-1001. 23. Nosho K, Yamamoto H, Adachi Y, Endo T, Hinoda Y, Imai K: Gene expression profiling of colorectal adenomas and early invasive carcinomas by cDNA array analysis. Br J Cancer 2005, 92(7):1193-1200. 24. Silletti S, Yebra M, Perez B, Cirulli V, McMahon M, Montgomery AM: Extracellular signal-regulated kinase (ERK)-dependent gene expression contributes to L1 cell adhesion molecule-dependent motility and invasion. J Biol Chem 2004, 279(28):28880-28888. 25. Lo CH, Lee SC, Wu PY, Pan WY, Su J, Cheng CW, Roffler SR, Chiang BL, Lee CN, Wu CW et al: Antitumor and antimetastatic activity of IL-23. J Immunol 2003, 171(2):600-607. 26. Zollo M, Andre A, Cossu A, Sini MC, D''Angelo A, Marino N, Budroni M, Tanda F, Arrigoni G, Palmieri G: Overexpression of h-prune in breast cancer is correlated with advanced disease status. Clin Cancer Res 2005, 11(1):199-205. 27. Chen XF, Zhang HT, Qi QY, Sun MM, Tao LY: Expression of E-cadherin and nm23 is associated with the clinicopathological factors of human non-small cell lung cancer in China. Lung Cancer 2005, 48(1):69-76. 28. Kao YR, Shih JY, Wen WC, Ko YP, Chen BM, Chan YL, Chu YW, Yang PC, Wu CW, Roffler SR: Tumor-associated antigen L6 and the invasion of human lung cancer cells. Clin Cancer Res 2003, 9(7):2807-2816. 29. Hemmerich S, Yarden Y, Pecht I: A cromoglycate binding protein from rat mast cells of a leukemia line is a nucleoside diphosphate kinase. Biochemistry 1992, 31(19):4574-4579. 30. Rosengard AM, Krutzsch HC, Shearn A, Biggs JR, Barker E, Margulies IM, King CR, Liotta LA, Steeg PS: Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development. Nature 1989, 342(6246):177-180. 31. Stahl JA, Leone A, Rosengard AM, Porter L, King CR, Steeg PS: Identification of a second human nm23 gene, nm23-H2. Cancer Res 1991, 51(1):445-449. 32. Venturelli D, Martinez R, Melotti P, Casella I, Peschle C, Cucco C, Spampinato G, Darzynkiewicz Z, Calabretta B: Overexpression of DR-nm23, a protein encoded by a member of the nm23 gene family, inhibits granulocyte differentiation and induces apoptosis in 32Dc13 myeloid cells. Proc Natl Acad Sci U S A 1995, 92(16):7435-7439. 33. Lombardi D, Lacombe ML, Paggi MG: nm23: unraveling its biological function in cell differentiation. J Cell Physiol 2000, 182(2):144-149. 34. Mehus JG, Deloukas P, Lambeth DO: NME6: a new member of the nm23/nucleoside diphosphate kinase gene family located on human chromosome 3p21.3. Hum Genet 1999, 104(6):454-459. 35. Milon L, Rousseau-Merck MF, Munier A, Erent M, Lascu I, Capeau J, Lacombe ML: nm23-H4, a new member of the family of human nm23/nucleoside diphosphate kinase genes localised on chromosome 16p13. Hum Genet 1997, 99(4):550-557. 36. Munier A, Feral C, Milon L, Pinon VP, Gyapay G, Capeau J, Guellaen G, Lacombe ML: A new human nm23 homologue (nm23-H5) specifically expressed in testis germinal cells. FEBS Lett 1998, 434(3):289-294. 37. Tsuiki H, Nitta M, Furuya A, Hanai N, Fujiwara T, Inagaki M, Kochi M, Ushio Y, Saya H, Nakamura H: A novel human nucleoside diphosphate (NDP) kinase, Nm23-H6, localizes in mitochondria and affects cytokinesis. J Cell Biochem 1999, 76(2):254-269. 38. Martinez R, Venturelli D, Perrotti D, Veronese ML, Kastury K, Druck T, Huebner K, Calabretta B: Gene structure, promoter activity, and chromosomal location of the DR-nm23 gene, a related member of the nm23 gene family. Cancer Res 1997, 57(6):1180-1187. 39. Amendola R, Martinez R, Negroni A, Venturelli D, Tanno B, Calabretta B, Raschella G: DR-nm23 gene expression in neuroblastoma cells: relationship to integrin expression, adhesion characteristics, and differentiation. J Natl Cancer Inst 1997, 89(17):1300-1310. 40. Lacombe ML, Milon L, Munier A, Mehus JG, Lambeth DO: The human Nm23/nucleoside diphosphate kinases. J Bioenerg Biomembr 2000, 32(3):247-258. 41. Sadek CM, Jimenez A, Damdimopoulos AE, Kieselbach T, Nord M, Gustafsson JA, Spyrou G, Davis EC, Oko R, van der Hoorn FA et al: Characterization of human thioredoxin-like 2. A novel microtubule-binding thioredoxin expressed predominantly in the cilia of lung airway epithelium and spermatid manchette and axoneme. JBiol Chem 2003, 278(15):13133-13142. 42. Bevilacqua G, Sobel ME, Liotta LA, Steeg PS: Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res 1989, 49(18):5185-5190. 43. Nakayama H, Yasui W, Yokozaki H, Tahara E: Reduced expression of nm23 is associated with metastasis of human gastric carcinomas. Jpn J Cancer Res 1993, 84(2):184-190. 44. Mandai M, Konishi I, Koshiyama M, Mori T, Arao S, Tashiro H, Okamura H, Nomura H, Hiai H, Fukumoto M: Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression. Cancer Res 1994, 54(7):1825-1830. 45. Engel M, Theisinger B, Seib T, Seitz G, Huwer H, Zang KD, Welter C, Dooley S: High levels of nm23-H1 and nm23-H2 messenger RNA in human squamous-cell lung carcinoma are associated with poor differentiation and advanced tumor stages. Int J Cancer 1993, 55(3):375-379. 46. Haut M, Steeg PS, Willson JK, Markowitz SD: Induction of nm23 gene expression in human colonic neoplasms and equal expression in colon tumors of high and low metastatic potential. J Natl Cancer Inst 1991, 83(10):712-716. 47. Myeroff LL, Markowitz SD: Increased nm23-H1 and nm23-H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potential. J Natl Cancer Inst 1993, 85(2):147-152. 48. Nakamori S, Ishikawa O, Ohigashi H, Imaoka S, Sasaki Y, Kameyama M, Kabuto T, Furukawa H, Iwanakga T, Kimura N: Clinicopathological features and prognostic significance of nucleoside diphosphate kinase/nm23 gene product in human pancreatic exocrine neoplasms. Int J Pancreatol 1993, 14(2):125-133. 49. Zou M, Shi Y, al-Sedairy S, Farid NR: High levels of Nm23 gene expression in advanced stage of thyroid carcinomas. Br J Cancer 1993, 68(2):385-388. 50. Tammenkoski M, Koivula K, Cusanelli E, Zollo M, Steegborn C, Baykov AA, Lahti R: Human metastasis regulator protein H-prune is a short-chain exopolyphosphatase. Biochemistry 2008, 47(36):9707-9713. 51. Garzia L, D''Angelo A, Amoresano A, Knauer SK, Cirulli C, Campanella C, Stauber RH, Steegborn C, Iolascon A, Zollo M: Phosphorylation of nm23-H1 by CKI induces its complex formation with h-prune and promotes cell motility. Oncogene 2008, 27(13):1853-1864. 52. Marone M, Scambia G, Ferrandina G, Giannitelli C, Benedetti-Panici P, Iacovella S, Leone A, Mancuso S: Nm23 expression in endometrial and cervical cancer: inverse correlation with lymph node involvement and myometrial invasion. Br J Cancer 1996, 74(7):1063-1068. 53. Blackburn EH: Structure and function of telomeres. Nature 1991, 350(6319):569-573. 54. Ishikawa F: [A review of the structure and function of human telomere]. Tanpakushitsu Kakusan Koso 1996, 41(15 Suppl):2241-2253. 55. Blasco MA, Rizen M, Greider CW, Hanahan D: Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat Genet 1996, 12(2):200-204. 56. Yashima K, Vuitch F, Gazdar AF, Fahey TJ, 3rd: Telomerase activity in benign and malignant thyroid diseases. Surgery 1997, 122(6):1141-1145; discussion 1145-1146. 57. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J et al: The RNA component of human telomerase. Science 1995, 269(5228):1236-1241. 58. Harrington L, McPhail T, Mar V, Zhou W, Oulton R, Bass MB, Arruda I, Robinson MO: A mammalian telomerase-associated protein. Science 1997, 275(5302):973-977. 59. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q et al: hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 1997, 90(4):785-795. 60. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR: Telomerase catalytic subunit homologs from fission yeast and human. Science 1997, 277(5328):955-959. 61. Harley CB, Futcher AB, Greider CW: Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345(6274):458-460. 62. Greider CW: Telomere length regulation. Annu Rev Biochem 1996, 65:337-365. 63. Kyo S, Kanaya T, Ishikawa H, Ueno H, Inoue M: Telomerase activity in gynecological tumors. Clin Cancer Res 1996, 2(12):2023-2028. 64. Sommerfeld HJ, Meeker AK, Piatyszek MA, Bova GS, Shay JW, Coffey DS: Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res 1996, 56(1):218-222. 65. Bednarek AK, Sahin A, Brenner AJ, Johnston DA, Aldaz CM: Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage. Clin Cancer Res 1997, 3(1):11-16. 66. Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW, Tahara E, Kajiyama G, Ide T: Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995, 55(13):2734-2736. 67. Langford LA, Piatyszek MA, Xu R, Schold SC, Jr., Wright WE, Shay JW: Telomerase activity in ordinary meningiomas predicts poor outcome. Hum Pathol 1997, 28(4):416-420. 68. Chakravarti A, Delaney MA, Noll E, Black PM, Loeffler JS, Muzikansky A, Dyson NJ: Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas. Clin Cancer Res 2001, 7(8):2387-2395. 69. Handra-Luca A, Bilal H, Bertrand JC, Fouret P: Extra-cellular signal-regulated ERK-1/ERK-2 pathway activation in human salivary gland mucoepidermoid carcinoma: association to aggressive tumor behavior and tumor cell proliferation. Am J Pathol 2003, 163(3):957-967. 70. Olaussen KA, Dunant A, Fouret P, Brambilla E, Andre F, Haddad V, Taranchon E, Filipits M, Pirker R, Popper HH et al: DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med 2006, 355(10):983-991. 71. Akiyama M, Hideshima T, Hayashi T, Tai YT, Mitsiades CS, Mitsiades N, Chauhan D, Richardson P, Munshi NC, Anderson KC: Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein. Cancer Res 2003, 63(1):18-21. 72. Liu K, Hodes RJ, Weng N: Cutting edge: telomerase activation in human T lymphocytes does not require increase in telomerase reverse transcriptase (hTERT) protein but is associated with hTERT phosphorylation and nuclear translocation. J Immunol 2001, 166(8):4826-4830. 73. Nakano K, Watney E, McDougall JK: Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer. Am J Pathol 1998, 153(3):857-864. 74. Sagawa Y, Nishi H, Isaka K, Fujito A, Takayama M: The correlation of TERT expression with c-myc expression in cervical cancer. Cancer Lett 2001, 168(1):45-50. 75. Wisman GB, De Jong S, Meersma GJ, Helder MN, Hollema H, de Vries EG, Keith WN, van der Zee AG: Telomerase in (pre)neoplastic cervical disease. Hum Pathol 2000, 31(10):1304-1312. 76. Tsezou A, Oikonomou P, Kollia P, Mademtzis I, Kostopoulou E, Messinis I, Vamvakopoulos N: The role of human telomerase catalytic subunit mRNA expression in cervical dysplasias. Exp Biol Med (Maywood) 2005, 230(4):263-270. 77. Zhang A, Wang J, Zheng B, Fang X, Angstrom T, Liu C, Li X, Erlandsson F, Bjorkholm M, Nordenskjord M et al: Telomere attrition predominantly occurs in precursor lesions during in vivo carcinogenic process of the uterine cervix. Oncogene 2004, 23(44):7441-7447. 78. Wang PH, Chang H, Ko JL, Lin LY: Nm23-H1 immunohistochemical expression in multisteps of cervical carcinogenesis. Int J Gynecol Cancer 2003, 13(3):325-330. 79. Ravazoula P, Aletra C, Kourounis G, Ladopoulos I, Tzigounis V: Immunohistochemical analysis of nm23-H1 expression in human cervical lesions. Eur J Gynaecol Oncol 2000, 21(5):510-512. 80. Branca M, Giorgi C, Ciotti M, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P et al: Down-regulated nucleoside diphosphate kinase nm23-H1 expression is unrelated to high-risk human papillomavirus but associated with progression of cervical intraepithelial neoplasia and unfavourable prognosis in cervical cancer. J Clin Pathol 2006, 59(10):1044-1051. 81. Weber G: Enzymology of cancer cells (first of two parts). N Engl J Med 1977, 296(9):486-492. 82. Ohneda K, Fukuda M, Shimada N, Ishikawa N, Ichou T, Kaji K, Toyota T, Kimura N: Increased expression of nucleoside diphosphate kinases/nm23 in human diploid fibroblasts transformed by SV40 large T antigen or 60Co irradiation. FEBS Lett 1994, 348(3):273-277. 83. Pinto AP, Crum CP: Natural history of cervical neoplasia: defining progression and its consequence. Clin Obstet Gynecol 2000, 43(2):352-362. 84. Bravaccini S, Sanchini MA, Amadori A, Medri L, Saragoni L, Calistri D, Monti F, Volpi A, Amadori D: Potential of telomerase expression and activity in cervical specimens as a diagnostic tool. J Clin Pathol 2005, 58(9):911-914. 85. Sarac E, Ayhan A, Ertoy D, Tuncer ZS, Yasui W, Tahara E: nm23 expression in carcinoma of the uterine cervix. Eur J Gynaecol Oncol 1998, 19(3):312-315. 86. Postel EH: Multiple biochemical activities of NM23/NDP kinase in gene regulation. J Bioenerg Biomembr 2003, 35(1):31-40. 87. Malins DC, Polissar NL, Gunselman SJ: Progression of human breast cancers to the metastatic state is linked to hydroxyl radical-induced DNA damage. Proc Natl Acad Sci U S A 1996, 93(6):2557-2563. 88. Malins DC, Polissar NL, Schaefer S, Su Y, Vinson M: A unified theory of carcinogenesis based on order-disorder transitions in DNA structure as studied in the human ovary and breast. Proc Natl Acad Sci U S A 1998, 95(13):7637-7642. 89. Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban RH, Hamilton SR, Vogelstein B, Kinzler KW: Gene expression profiles in normal and cancer cells. Science 1997, 276(5316):1268-1272. 90. Pinon VP, Millot G, Munier A, Vassy J, Linares-Cruz G, Capeau J, Calvo F, Lacombe ML: Cytoskeletal association of the A and B nucleoside diphosphate kinases of interphasic but not mitotic human carcinoma cell lines: specific nuclear localization of the B subunit. Exp Cell Res 1999, 246(2):355-367. 91. Yamashiro S, Urano T, Shiku H, Furukawa K: Alteration of nm23 gene expression during the induced differentiation of human leukemia cell lines. Oncogene 1994, 9(9):2461-2468. 92. Sager R: Expression genetics in cancer: shifting the focus from DNA to RNA. Proc Natl Acad Sci U S A 1997, 94(3):952-955. 93. Sirotkovic-Skerlev M, Krizanac S, Kapitanovic S, Husnjak K, Unusic J, Pavelic K: Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters. Exp Mol Pathol 2005, 79(1):42-50. 94. Valentijn LJ, Koppen A, van Asperen R, Root HA, Haneveld F, Versteeg R: Inhibition of a new differentiation pathway in neuroblastoma by copy number defects of N-myc, Cdc42, and nm23 genes. Cancer Res 2005, 65(8):3136-3145. 95. D''Angelo A, Garzia L, Andre A, Carotenuto P, Aglio V, Guardiola O, Arrigoni G, Cossu A, Palmieri G, Aravind L et al: Prune cAMP phosphodiesterase binds nm23-H1 and promotes cancer metastasis. Cancer Cell 2004, 5(2):137-149. 96. Fan Z, Beresford PJ, Oh DY, Zhang D, Lieberman J: Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell 2003, 112(5):659-672. 97. Forus A, D''Angelo A, Henriksen J, Merla G, Maelandsmo GM, Florenes VA, Olivieri S, Bjerkehagen B, Meza-Zepeda LA, del Vecchio Blanco F et al: Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas-a possible mechanism for altering the nm23-H1 activity. Oncogene 2001, 20(47):6881-6890. 98. Habets GG, Scholtes EH, Zuydgeest D, van der Kammen RA, Stam JC, Berns A, Collard JG: Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell 1994, 77(4):537-549. 99. Marino N, Zollo M: Understanding h-prune biology in the fight against cancer. Clin Exp Metastasis 2007, 24(8):637-645. 100. Otsuki Y, Tanaka M, Yoshii S, Kawazoe N, Nakaya K, Sugimura H: Tumor metastasis suppressor nm23H1 regulates Rac1 GTPase by interaction with Tiam1. Proc Natl Acad Sci U S A 2001, 98(8):4385-4390. 101. Reymond A, Volorio S, Merla G, Al-Maghtheh M, Zuffardi O, Bulfone A, Ballabio A, Zollo M: Evidence for interaction between human PRUNE and nm23-H1 NDPKinase. Oncogene 1999, 18(51):7244-7252. 102. Valentijn LJ, Koster J, Versteeg R: Read-through transcript from NM23-H1 into the neighboring NM23-H2 gene encodes a novel protein, NM23-LV. Genomics 2006, 87(4):483-489. 103. Ni X, Gu S, Dai J, Cheng H, Guo L, Li L, Ji C, Xie Y, Ying K, Mao Y: Isolation and characterization of a novel human NM23-H1B gene, a different transcript of NM23-H1. J Hum Genet 2003, 48(2):96-100. 104. Kristensen GB, Holm R, Abeler VM, Trope CG: Evaluation of the prognostic significance of nm23/NDP kinase protein expression in cervical carcinoma: an immunohistochemical study. Gynecol Oncol 1996, 61(3):378-383.
|